2012
DOI: 10.5581/1516-8484.20120041
|View full text |Cite
|
Sign up to set email alerts
|

Sickle cell disease: looking back but towards the future

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 16 publications
0
12
0
Order By: Relevance
“…Sickle cell disease (SCD) is a multisystem disease associated with episodes of acute illness and progressive organ damage, and it represents a major public health problem because of its associated morbidity and mortality [ 1 ]. The prevalence of sickle hemoglobin (Hb S) in Basra is 6.48%, with a gene frequency of 0.0324% [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Sickle cell disease (SCD) is a multisystem disease associated with episodes of acute illness and progressive organ damage, and it represents a major public health problem because of its associated morbidity and mortality [ 1 ]. The prevalence of sickle hemoglobin (Hb S) in Basra is 6.48%, with a gene frequency of 0.0324% [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…(21) The advent of neonatal screening, antibiotic prophylaxis, better vaccines, safer blood transfusion, iron chelation, and hydroxyurea therapy have improved the survival of patients with SCD. (17,(23)(24)(25)(26)(27) The life expectancy of children has increased, and SCD changed from a childhood disease to become a chronic disease. (14,16,24,26) However, for adult patients, mortality remains high.…”
Section: Discussionmentioning
confidence: 99%
“…Up to the fifth year of life, the period of the highest rates of serious complications and death, "prophylactic treatment is basically the essence of therapy". (7,24) However, regular treatment, adherence to treatment, family support, and lifestyle are important for reducing morbidity and mortality. (9) In the state of MS, human and technological resources are concentrated in the municipalities of Campo Grande and Dourados, revealing a low resolution for the treatment of hemoglobinopathies in health microregions.…”
Section: Discussionmentioning
confidence: 99%
“…Sickle cell disease (SCD) is an inherited haemoglobinopathy, which is a severe monogenic condition that affects millions of people worldwide, and characterized by formation of abnormal hemoglobin called Hb S, repeated cycles of sickling and unsickling, multiple episodes of vascular obstruction, and hemolytic anemia (1) . During sickling process, interaction between the rigid sickle cells and the vascular wall leads to, intravascular thrombosis and subsequent end-organ ischemia (1,2) . Stroke caused by vaso-occlusion is a major complication of SCD.…”
Section: Introductionmentioning
confidence: 99%